FDA approves Doptelet (avatrombopag) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical procedure.
Read more: FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure